Vanda Pharmaceuticals Inc. share price logo

Vanda Pharmaceuticals Inc. Share Price

NASDAQ: VNDA

Small Cap

$4.51

-0.08

(-1.85%)

as on

Vanda Pharmaceuticals Inc. Stock Performance

as on September 13, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $4.47
    $4.55
    downward going graph

    0.89%

    Downside

    0.89%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $3.81
    $5.55
    downward going graph

    15.54%

    Downside

    22.95%

    Upside

    downward going graph

Vanda Pharmaceuticals Inc. share price movements today

Previous Close
$4.60
Open
$4.55
Volume
418.6K
Day's Low - High
$4.47 - $4.55
52 Week Low - High
$3.81 - $5.55

Vanda Pharmaceuticals Inc. Historical Returns

1 Month Return
+ 3.44 %
3 Month Return
0 %
1 Year Return
-11.57 %
3 Year Return
-55.52 %
5 Year Return
-53.17 %

Vanda Pharmaceuticals Inc. Stock Fundamentals & Key Indicators

Check Vanda Pharmaceuticals Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$266.5M

EPS (TTM)

-1.8067

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.96%

PE Ratio (TTM)

-27.85

Industry PE ratio

-3.8535542168674697

P/B Ratio

0

PEG Ratio

-2.42

EBITDA

-92.9M

Revenue (TTM)

203.5M

Profit Margin

-32.90%

Return On Equity TTM

6221900.00%

Vanda Pharmaceuticals Inc. Stock Valuation

Track how Vanda Pharmaceuticals Inc. P/E has moved over time to understand its valuation trends.

Vanda Pharmaceuticals Inc. in the last 5 years

  • Overview

  • Trends

Lowest (23.74x)

June 30, 2023

Today (-27.85x)

September 15, 2025

Industry (-3.85x)

September 15, 2025

Highest (87.99x)

September 30, 2022

LowHigh

Today’s Price to Earnings Ratio: -27.85x

Vanda Pharmaceuticals Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Vanda Pharmaceuticals Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$266.5M-53.17%-27.85-32.90%
BUY$61.1B280.5%-505.15-12.96%
NA$37.7BNANA-3.89%
BUY$101.2B54.04%28.0831.86%
BUY$59.4B2.03%14.1131.37%

Stock Returns calculator for Vanda Pharmaceuticals Inc. Stock including INR - Dollar returns

The Vanda Pharmaceuticals Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Vanda Pharmaceuticals Inc. investment value today

Current value as on today

₹93,570

Returns

₹6,430

(-6.43%)

Returns from Vanda Pharmaceuticals Inc. Stock

₹11,569 (-11.57%)

Dollar Returns*

₹5,139 (+5.14%)

Analyst Recommendation on Vanda Pharmaceuticals Inc. Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Vanda Pharmaceuticals Inc.. Average target price of $12.67

Vanda Pharmaceuticals Inc. Share Price Target

Get share price movements and forecasts by analysts on Vanda Pharmaceuticals Inc..

What analysts predicted

64.4%UPSIDE

Target Price

$12.67

Current Price

$4.51

Analyzed by

7 Analysts

Target

$12.67

Vanda Pharmaceuticals Inc. target price $12.67, a slight upside of 64.4% compared to current price of $4.51. According to 7 analysts rating.

Vanda Pharmaceuticals Inc. Stock's Interest Amongst Investors

Search interest for Vanda Pharmaceuticals Inc. Stock has decreased by -7% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-7% versus previous 30 day period

Vanda Pharmaceuticals Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
62
46
38
45
47
50
47
53
50
52
Gross Profit
57
42
35
41
42
45
45
50
46
48
Operating Income
2
-2
-5
-7
-9
-10
-11
-10
-44
-38
EBITDA
2
-2
-5
-5
-7
-8
-9
-8
-31
-32
Interest Expense
3
-
-
3
-
-
-
-
-
-
Depreciation
0
0
0
1
2
1
1
1
1
2
Income Before Tax
5
2
0
-1
-4
-5
-6
-6
-37
-34
Income Tax Expense
2
1
0
0
0
0
0
-1
-7
-7
Net Income
3
1
0
-2
-4
-4
-5
-4
-29
-27
Net Profit Margin
5.20%
3.30%
0.35%
-5.30%
-8.74%
-8.95%
-11.17%
-9.24%
-58.94%
-51.73%

Vanda Pharmaceuticals Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
109
146
165
193
227
248
268
254
192
198
Gross Profit
86
121
147
172
202
224
243
230
192
187
Operating Income
-40
-18
-16
21
22
27
42
6
-13
-40
EBITDA
-26
-6
-13
24
25
30
45
9
-13
-32
Interest Expense
-
-
-
-
6
4
0
4
-
-
Depreciation
-
-
2
2
2
2
2
2
2
8
Income Before Tax
-39
-17
-15
25
29
31
42
11
6
-22
Income Tax Expense
-
0
0
0
-86
8
9
5
3
-4
Net Income
-39
-18
-15
25
115
23
33
6
2
-18
Net Profit Margin
-36.27%
-12.33%
-9.43%
13.05%
50.86%
9.40%
12.34%
2.47%
1.30%
-9.51%

Vanda Pharmaceuticals Inc. Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
1
0
-2
-4
-4
-5
-4
-29
-27
Operating Cash Flow
-13
-2
-3
7
-6
-14
-1
-33
-15
Investing Cash Flow
-190
35
-43
-18
-15
12
3
43
-15
Financing Cash Flow
-
-
-
-
-
-
0
-1
0
Change in Cash
-204
33
-47
-10
-22
-2
1
9
-30

Vanda Pharmaceuticals Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-18
-15
25
115
23
33
6
2
-18
Operating Cash Flow
-8
-1
29
45
51
64
31
12
-15
Investing Cash Flow
-10
-10
-109
-68
-41
-76
49
-12
-17
Financing Cash Flow
7
5
107
6
5
3
0
0
0
Change in Cash
-10
-6
27
-16
15
-9
82
0
-33

Global Institutional Holdings in Vanda Pharmaceuticals Inc.

Funds
Holdings
BlackRock Inc
15.45%
Renaissance Technologies Corp
6.04%
Vanguard Group Inc
5.92%
Dimensional Fund Advisors, Inc.
4.3%
TANG CAPITAL MANAGEMENT LLC
3.98%

Insights on Vanda Pharmaceuticals Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 50.04M → 52.59M (in $), with an average increase of 4.9% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -29.49M → -27.20M (in $), with an average increase of 8.4% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 179.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.6% return, outperforming this stock by 87.2%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, VNDA stock has moved down by -55.5%

About Vanda Pharmaceuticals Inc.

vanda is a specialty pharmaceutical company focused on the development and commercialization of novel therapies to address high unmet medical needs and improve the lives of patients.
OrganisationVanda Pharmaceuticals Inc.
Headquarters2200 Pennsylvania Avenue NW, Washington, DC, United States, 20037
IndustryHealth Technology
CEODr. Mihael H. Polymeropoulos M.D.
E-voting on sharesClick here to vote

Key Management of Vanda Pharmaceuticals Inc.

Name

Title

Dr. Mihael H. Polymeropoulos M.D.

Founder, President, CEO & Chairman of The Board

Mr. Kevin Patrick Moran

Senior VP, CFO & Treasurer

Mr. Timothy Williams J.D.

Senior VP, General Counsel & Secretary

Mr. Joakim Wijkstrom

Senior VP & Chief Marketing Officer

Mr. Gunther Birznieks

Senior Vice President of Business Development

Mr. Scott L. Howell

Chief People Officer

FAQs

What is Vanda Pharmaceuticals Inc. share price today?

Vanda Pharmaceuticals Inc. share price today is $4.51 as on at the close of the market. Vanda Pharmaceuticals Inc. share today touched a day high of $4.55 and a low of $4.47.

What is the 52 week high and 52 week low for Vanda Pharmaceuticals Inc. share?

Vanda Pharmaceuticals Inc. share touched a 52 week high of $5.55 on and a 52 week low of $3.81 on . Vanda Pharmaceuticals Inc. stock price today i.e. is closed at $4.51,which is 18.67% down from its 52 week high and 18.40% up from its 52 week low.

What is Vanda Pharmaceuticals Inc.'s market capitalisation today?

Vanda Pharmaceuticals Inc. market capitalisation is $0.00T as on .

How to invest in Vanda Pharmaceuticals Inc. Stock (VNDA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Vanda Pharmaceuticals Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Vanda Pharmaceuticals Inc. Shares that will get you 0.3326 shares as per Vanda Pharmaceuticals Inc. share price of $4.51 per share as on September 13, 2025 at 1:29 am IST.

What is the minimum amount required to buy Vanda Pharmaceuticals Inc. Stock (VNDA) from India?

Indian investors can start investing in Vanda Pharmaceuticals Inc. (VNDA) shares with as little as ₹88.27 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Vanda Pharmaceuticals Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Vanda Pharmaceuticals Inc. share’s latest price of $4.51 as on September 13, 2025 at 1:29 am IST, you will get 2.2173 shares of Vanda Pharmaceuticals Inc.. Learn more about fractional shares .

What are the returns that Vanda Pharmaceuticals Inc. has given to Indian investors in the last 5 years?

Vanda Pharmaceuticals Inc. stock has given -53.17% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?